ResearcherQingdao UniversityActive in the last 2 years

Chao Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3893-7224; OpenAlex author ID A5100748612. Sources: OpenAlex.

Their work

Papers: 4 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 15

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 4

Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via the macrophage migration inhibitory facto… Co-author DOI 10.1038/s41392-025-02562-8 ↗
Design of nano-delivery systems for pancreatic cancer immunotherapy. First author DOI 10.1016/j.canlet.2025.218098 ↗
Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens. First author DOI 10.3390/cancers17040692 ↗
Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy. Co-author DOI 10.1021/acs.nanolett.2c01994 ↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ruining Gong · 3 shared papers, 2022–2026 · strength 0.60
He Ren · 3 shared papers, 2022–2026 · strength 0.60
Qian Yu · 2 shared papers, 2025–2026 · strength 0.42
- Paper Design of nano-delivery systems for pancreatic cancer immunotherapy. DOI 10.1016/j.canlet.2025.218098 ↗
- Paper Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via t… DOI 10.1038/s41392-025-02562-8 ↗
Meijuan Wang · 1 shared paper, 2025 · strength 0.27
- Paper Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens. DOI 10.3390/cancers17040692 ↗
Lianyong Li · 1 shared paper, 2025 · strength 0.27
- Paper Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens. DOI 10.3390/cancers17040692 ↗
Shunli Fu · 1 shared paper, 2025 · strength 0.24
- Paper Design of nano-delivery systems for pancreatic cancer immunotherapy. DOI 10.1016/j.canlet.2025.218098 ↗
Zhan Yang · 1 shared paper, 2025 · strength 0.24
- Paper Design of nano-delivery systems for pancreatic cancer immunotherapy. DOI 10.1016/j.canlet.2025.218098 ↗
Huan Zhang · 1 shared paper, 2026 · strength 0.19
- Paper Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via t… DOI 10.1038/s41392-025-02562-8 ↗
Shanglong Liu · 1 shared paper, 2026 · strength 0.19
- Paper Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via t… DOI 10.1038/s41392-025-02562-8 ↗
Xiaoya Shi · 1 shared paper, 2026 · strength 0.19
- Paper Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via t… DOI 10.1038/s41392-025-02562-8 ↗
Qinghui Niu · 1 shared paper, 2026 · strength 0.19
- Paper Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via t… DOI 10.1038/s41392-025-02562-8 ↗
Ashok Kumar Saluja · 1 shared paper, 2026 · strength 0.19
- Paper Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via t… DOI 10.1038/s41392-025-02562-8 ↗
Jieer Ying · 1 shared paper, 2026 · strength 0.19
- Paper Metabolic dysfunction-associated steatotic liver disease accelerates pancreatic cancer progression and metastasis via t… DOI 10.1038/s41392-025-02562-8 ↗
Xiao Zhao · 1 shared paper, 2022 · strength 0.17
- Paper Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pan… DOI 10.1021/acs.nanolett.2c01994 ↗
Guangjun Nie · 1 shared paper, 2022 · strength 0.17
- Paper Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pan… DOI 10.1021/acs.nanolett.2c01994 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.